Nektar Therapeutics Construction in Progress, Gross
Nektar Therapeutics (NKTR) had Construction in Progress, Gross of $245.00 thousand as of 2024-12-31, per its 10-K filed 2025-03-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:ConstructionInProgressGross · last filed 2025-03-14
- 2024-12-31: Construction in Progress, Gross $245.00K.
- 2024-09-30: Construction in Progress, Gross $138.00K.
- 2024-06-30: Construction in Progress, Gross $724.00K.
- 2023-12-31: Construction in Progress, Gross $739.00K.
| Period end | Construction in Progress, Gross | Construction in Progress, Gross as first filed |
|---|---|---|
| 2024-12-31 | $245.00K 10-K · filed 2025-03-14 | |
| 2024-09-30 | $138.00K 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $724.00K 10-Q · filed 2024-08-09 | |
| 2023-12-31 | $739.00K 10-K · filed 2025-03-14 | |
| 2023-09-30 | $488.00K 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $461.00K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $811.00K 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $2.53M 10-K · filed 2024-03-05 | |
| 2021-12-31 | $7.16M 10-K · filed 2023-02-28 | |
| 2020-12-31 | $4.70M 10-K · filed 2022-03-01 | |
| 2019-12-31 | $5.22M 10-K · filed 2021-02-26 | $4.55M 10-K · filed 2020-02-28 |
| 2018-12-31 | $5.09M 10-K · filed 2020-02-28 | |
| 2017-12-31 | $1.40M 10-K · filed 2019-03-01 | |
| 2016-12-31 | $3.46M 10-K · filed 2018-03-01 | |
| 2015-12-31 | $8.46M 10-K · filed 2017-03-01 | |
| 2014-12-31 | $16.31M 10-K · filed 2016-02-29 | |
| 2013-12-31 | $6.26M 10-K · filed 2015-02-26 | |
| 2012-12-31 | $2.77M 10-K · filed 2014-02-27 | |
| 2011-12-31 | $1.75M 10-K · filed 2013-03-01 | |
| 2010-12-31 | $2.56M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |